RT Journal Article
SR Electronic
T1 Survival prediction with Bayesian Networks in more than 6000 non-small cell lung cancer patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.27.21263258
DO 10.1101/2021.09.27.21263258
A1 Dekker, A.L.A.J.
A1 Hope, A.
A1 Lambin, P.
A1 Lindsay, P.
YR 2021
UL http://medrxiv.org/content/early/2021/09/27/2021.09.27.21263258.abstract
AB A model that predicts survival in lung cancer as a function of treatment choices would be valuable for decision support. In this study we built data flow tasks and a data warehouse to collect from clinical databases a large non-small cell lung cancer dataset from MAASTRO (N=1781) and from Princess Margaret Hospital (PMH, N=4591). We learned Bayesian Network (BN) models for survival prediction from the MAASTRO data and evaluated the models in the PMH dataset. The BN model based on stage and radiotherapy dose had a high predictive accuracy (AUC 0.917). The model correctly showed that radical radiotherapy (>60Gy) is beneficial for non-small cell lung cancer patients and that this benefit is disease stage dependent.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Internal Review Board of the Princess Margaret Hospital in Toronto, Canada and the Internal Review Board of Maastro Clinic in Maastricht, The Netherlands have both given ethical approval to this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot publicly available due to privacy